Bifidobacterium lactisand Diarrhea.
Evidence gradeA
ImpactStrong
Confidencehigh
Imported rating. This grade comes from SuppCo and has not been independently reviewed. It describes research, not a product, and it is not medical advice.
The rating
- Direction
- Favourable
- Rated by
- SuppCo
- Observed
- 28 September 2026
Studies behind it
Bifidobacterium lactis CCT 7858 Improves Gastrointestinal Symptoms by Antibiotics Treatment: a Double-Blind, Randomized, Placebo-Controlled TrialMonique Michels · Probiotics and Antimicrobial Proteins2022Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A ReviewJing Cheng · Frontiers in Nutrition2021Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled studyKe Chen · European Journal of Clinical Nutrition2024